Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02053636
Recruitment Status : Completed
First Posted : February 4, 2014
Last Update Posted : April 26, 2018
Sponsor:
Collaborator:
Breast International Group
Information provided by (Responsible Party):
Servier

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2017
  Actual Study Completion Date : April 4, 2017